BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 11812557)

  • 1. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.
    Beutler E; Felitti VJ; Koziol JA; Ho NJ; Gelbart T
    Lancet; 2002 Jan; 359(9302):211-8. PubMed ID: 11812557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population.
    Merryweather-Clarke AT; Worwood M; Parkinson L; Mattock C; Pointon JJ; Shearman JD; Robson KJ
    Br J Haematol; 1998 May; 101(2):369-73. PubMed ID: 9609537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration?
    Ryan E; Byrnes V; Coughlan B; Flanagan AM; Barrett S; O'Keane JC; Crowe J
    Gut; 2002 Jul; 51(1):108-12. PubMed ID: 12077102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene.
    Waalen J; Felitti V; Gelbart T; Ho NJ; Beutler E
    Mayo Clin Proc; 2002 Jun; 77(6):522-30. PubMed ID: 12059121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of haemochromatosis gene mutations in the general population: implications for screening.
    Burt MJ; George PM; Upton JD; Collett JA; Frampton CM; Chapman TM; Walmsley TA; Chapman BA
    Gut; 1998 Dec; 43(6):830-6. PubMed ID: 9824612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
    Pedersen P; Milman N
    Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testing.
    Watkins S; Thorburn D; Joshi N; Neilson M; Joyce T; Spooner R; Cooke A; Mills PR; Morris AJ; Stanley AJ
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):379-83. PubMed ID: 18403938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 French people.
    Deugnier Y; Jouanolle AM; Chaperon J; Moirand R; Pithois C; Meyer JF; Pouchard M; Lafraise B; Brigand A; Caserio-Schoenemann C; Mosser J; Adams P; Le Gall JY; David V
    Br J Haematol; 2002 Sep; 118(4):1170-8. PubMed ID: 12199803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of primary hemochromatosis].
    Swinkels DW; Marx JJ
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1404-8. PubMed ID: 10422553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?
    de Diego C; Opazo S; Murga MJ; Martínez-Castro P
    Eur J Haematol; 2007 Jan; 78(1):66-71. PubMed ID: 17042772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase.
    Bhavnani M; Lloyd D; Bhattacharyya A; Marples J; Elton P; Worwood M
    Gut; 2000 May; 46(5):707-10. PubMed ID: 10764716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of haemochromatosis.
    Bomford A
    Lancet; 2002 Nov; 360(9346):1673-81. PubMed ID: 12457803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetrance, cancer incidence and survival in HFE haemochromatosis-A population-based cohort study.
    Schaefer B; Pammer LM; Pfeifer B; Neururer S; Troppmair MR; Panzer M; Wagner S; Pertler E; Gieger C; Kronenberg F; Lamina C; Tilg H; Zoller H
    Liver Int; 2024 Mar; 44(3):838-847. PubMed ID: 38263707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary haemochromatosis mutation frequencies in the general population.
    Bradley LA; Johnson DD; Palomaki GE; Haddow JE; Robertson NH; Ferrie RM
    J Med Screen; 1998; 5(1):34-6. PubMed ID: 9575458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of the Cys282Tyr HFE mutation facilitates an improved diagnostic service for hereditary haemochromatosis in South Africa.
    de Villiers JN; Hillerman R; de Jong G; Langenhoven E; Rossouw H; Marx MP; Kotze MJ
    S Afr Med J; 1999 Mar; 89(3):279-82. PubMed ID: 10226674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Searching for hereditary hemochromatosis.
    Laudicina RJ
    Clin Lab Sci; 2006; 19(3):174-83. PubMed ID: 16910235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study.
    Ellervik C; Mandrup-Poulsen T; Nordestgaard BG; Larsen LE; Appleyard M; Frandsen M; Petersen P; Schlichting P; Saermark T; Tybjaerg-Hansen A; Birgens H
    Lancet; 2001 Oct; 358(9291):1405-9. PubMed ID: 11705485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic haemochromatosis.
    Rosalki SB
    Int J Clin Pract; 2002 Oct; 56(8):609-10. PubMed ID: 12425371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
    Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M
    Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of transferrin saturation as a screening test for hereditary haemochromatosis in an Irish population seeking medical care.
    O'Hara R; Cavanagh N; Cassidy M; Cullina M
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):169-74. PubMed ID: 12662406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.